Cancer Drug Repairs Memory Cells in Mice
A new drug created for the destruction of cancer cells, has surprised the manufacturer Astra Zeneca. Though the new drug AZD05030 did not annihilate the cancerous tumor as had been hoped for, this new drug did block damage started because of the amyloid-beta plaques in the brain of mice.
Innovative National Institutes of Health (NIH) is a program that offers test trials on different diseases. After a test drug has failed on one disease they may test it’s effectiveness on other diseases.
AZD05030 is just such a drug. After it was created to obliterate cancer but failed, it was tested and found to block the plaque that blocks memory for those with Alzheimer’s. Human study trials have begun to test the full value of this new drug, known as AZD05030, in Alzheimer’s Patients.
“With this treatment, cells under bombardment by beta amyloid plaques show restored synaptic connections and reduced inflammation, and the animal’s memory, which was lost during the course of the disease, comes back,” said Stephen M. Strittmatter, the Vincent Coates Professor of Neurology and senior author of the study.
During the last five years, scientists have gained a better understanding of the development of Alzheimer’s. And this new drug blocks one of the major steps in the beginnings of Alzheimer’s.
Since it has been rushed to Trials, we can only hope for more beneficial discoveries from this drug in the near future.
More information is available at: Medical News Today